Analysis of the Gut Microbiota: An Emerging Source of Biomarkers for Immune Checkpoint Blockade Therapy in Non-Small Cell Lung Cancer

SIMPLE SUMMARY: The immune checkpoint blockade (ICB), and concretely the blockade of the PD1/PDL1 axis, has opened up a new standard of treatment for non-small cell lung cancer (NSCLC). However, despite substantial advances in clinical care, many patients still remain refractory to these therapies....

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cancers (Basel)
मुख्य लेखकों: Zhang, Feiyu, Ferrero, Macarena, Dong, Ning, D’Auria, Giuseppe, Reyes-Prieto, Mariana, Herreros-Pomares, Alejandro, Calabuig-Fariñas, Silvia, Duréndez, Elena, Aparisi, Francisco, Blasco, Ana, García, Clara, Camps, Carlos, Jantus-Lewintre, Eloisa, Sirera, Rafael
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: MDPI 2021
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8196639/
https://ncbi.nlm.nih.gov/pubmed/34063829
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13112514
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन